This inventor holds 2 USPTO granted patents. Top assignees: Biotie Therapies Corporation, Elbion Ag. Active years: 2007-2011.
Company Filing History:
Years Active: 2007-2011
Title: Matthias Olbrich - Innovator in Therapeutic Agents
Introduction
Matthias Olbrich, an accomplished inventor based in Moritzburg, Germany, has made significant contributions to the field of pharmaceuticals, particularly through his work on 7-azaindoles. With a total of two patents to his name, his innovative efforts focus on developing therapeutic agents that play a crucial role in treating various disorders.
Latest Patents
Matthias Olbrich's latest patents revolve around the invention of substituted 7-azaindoles. These patents detail a process for their preparation and highlight the pharmaceutical applications of these compounds. They serve as inhibitors of phosphodiesterase 4, which can influence disorders in immunocompetent cells such as macrophages and lymphocytes. This promising research paves the way for new treatments that could significantly impact patient care.
Career Highlights
Throughout his career, Matthias has worked with leading companies in the pharmaceutical industry, including Elbion AG and Biotie Therapies Corporation. His expertise in therapeutic agents has positioned him as a valuable asset in these organizations, contributing to the advancement of innovative medical solutions.
Collaborations
Matthias Olbrich has had the privilege to collaborate with notable professionals in the field, including Hildegard Kuss and Ute Egerland. These collaborations have further enriched his research and helped in the advancement of therapeutic inventions.
Conclusion
In summary, Matthias Olbrich stands out as a vital inventor within the pharmaceutical landscape. With his pioneering work on 7-azaindoles and strong collaborative efforts, he continues to drive innovation in creating effective therapeutic agents.